These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Planté-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C, THAOS Investigators. J Am Coll Cardiol; 2016 Jul 12; 68(2):161-72. PubMed ID: 27386769 [Abstract] [Full Text] [Related]
3. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals. Parcha V, Malla G, Irvin MR, Armstrong ND, Judd SE, Lange LA, Maurer MS, Levitan EB, Goyal P, Arora G, Arora P. JAMA; 2022 Apr 12; 327(14):1368-1378. PubMed ID: 35377943 [Abstract] [Full Text] [Related]
4. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology. Skrahina V, Grittner U, Beetz C, Skripuletz T, Juenemann M, Krämer HH, Hahn K, Rieth A, Schaechinger V, Patten M, Tanislav C, Achenbach S, Assmus B, Knebel F, Gingele S, Skrahin A, Hartkamp J, Förster TM, Roesner S, Pereira C, Rolfs A. Ann Med; 2021 Dec 12; 53(1):1787-1796. PubMed ID: 34658264 [Abstract] [Full Text] [Related]
5. Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis. Dungu JN, Papadopoulou SA, Wykes K, Mahmood I, Marshall J, Valencia O, Fontana M, Whelan CJ, Gillmore JD, Hawkins PN, Anderson LJ. Circ Heart Fail; 2016 Sep 12; 9(9):. PubMed ID: 27618855 [Abstract] [Full Text] [Related]
6. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Coelho T, Maurer MS, Suhr OB. Curr Med Res Opin; 2013 Jan 12; 29(1):63-76. PubMed ID: 23193944 [Abstract] [Full Text] [Related]
7. Cardiac Amyloidosis Due to Transthyretin Protein: A Review. Ruberg FL, Maurer MS. JAMA; 2024 Mar 05; 331(9):778-791. PubMed ID: 38441582 [Abstract] [Full Text] [Related]
8. The genetic heterogeneity of hereditary transthyretin amyloidosis in a sample of the Brazilian population. Lavigne-Moreira C, Marques VD, Gonçalves MVM, de Oliveira MF, Tomaselli PJ, Nunez JC, do Nascimento OJM, Barreira AA, Marques W. J Peripher Nerv Syst; 2018 Jun 05; 23(2):134-137. PubMed ID: 29520877 [Abstract] [Full Text] [Related]
9. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Connors LH, Prokaeva T, Lim A, Théberge R, Falk RH, Doros G, Berg A, Costello CE, O'Hara C, Seldin DC, Skinner M. Am Heart J; 2009 Oct 05; 158(4):607-14. PubMed ID: 19781421 [Abstract] [Full Text] [Related]
10. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry. Parker MM, Damrauer SM, Tcheandjieu C, Erbe D, Aldinc E, Hawkins PN, Gillmore JD, Hull LE, Lynch JA, Joseph J, Ticau S, Flynn-Carroll AO, Deaton AM, Ward LD, Assimes TL, Tsao PS, Chang KM, Rader DJ, Fitzgerald K, Vaishnaw AK, Hinkle G, Nioi P. Sci Rep; 2021 Jun 02; 11(1):11645. PubMed ID: 34079032 [Abstract] [Full Text] [Related]
11. Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial. Waddington-Cruz M, Ackermann EJ, Polydefkis M, Heitner SB, Dyck PJ, Barroso FA, Wang AK, Berk JL, Dyck PJB, Monia BP, Hughes SG, Tai L, Jesse Kwoh T, Jung SW, Coelho T, Benson MD, Gertz MA. Amyloid; 2018 Sep 02; 25(3):180-188. PubMed ID: 30169969 [Abstract] [Full Text] [Related]
12. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. N Engl J Med; 1997 Feb 13; 336(7):466-73. PubMed ID: 9017939 [Abstract] [Full Text] [Related]
13. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy. Porcari A, Razvi Y, Masi A, Patel R, Ioannou A, Rauf MU, Hutt DF, Rowczenio D, Gilbertson J, Martinez-Naharro A, Venneri L, Whelan C, Lachmann H, Wechalekar A, Quarta CC, Merlo M, Sinagra G, Hawkins PN, Fontana M, Gillmore JD. Eur J Heart Fail; 2023 Apr 13; 25(4):515-524. PubMed ID: 36644836 [Abstract] [Full Text] [Related]